Cofactors of drug hypersensitivity-A monocenter retrospective analysis.
antibiotic
beta-lactam
cofactor
drug allergy
drug hypersensitivity reaction
multiple logistic regression
nonopioid analgesic
Journal
Frontiers in allergy
ISSN: 2673-6101
Titre abrégé: Front Allergy
Pays: Switzerland
ID NLM: 9918227355906676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
11
2022
accepted:
07
12
2022
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
24
1
2023
Statut:
epublish
Résumé
Drug hypersensitivity reactions (DHRs) are major medical problems that influence the treatment of patients by both under- and overdiagnosis. Still, little is known about the role of predisposing or protecting cofactors of DHR. This study aims to determine drug-specific cofactors in patients with DHR. Retrospective file chart analysis of inpatients with suspected DHR in our department between 2015 and 2020 was performed. Descriptive statistics and multiple logistic regression were conducted for the estimation and statistical interference. DHRs were suspected in 393 patients with 678 culprit drugs. In 183 cases, drug hypersensitivities were confirmed, mostly against nonopioid analgesic drugs and antibiotics. Multiple logistic regression analysis identified a positive association of antibiotic hypersensitivity with obesity [odds ratio (OR) 5.75, average marginal effect (AME) +24.4%] and age and a negative association with arterial hypertension, female sex, elevated immunoglobulin E (IgE), and allergic rhinitis. Hypersensitivity to nonopioid analgesics was associated with atopic dermatitis (OR 10.28, AME +28.5%), elevated IgE, and arterial hypertension. Drug-specific cofactors of DHR include obesity for antibiotics and atopic dermatitis for nonopioid analgesics, the knowledge of which may improve the risk calculation for drug provocation tests.
Sections du résumé
Background
UNASSIGNED
Drug hypersensitivity reactions (DHRs) are major medical problems that influence the treatment of patients by both under- and overdiagnosis. Still, little is known about the role of predisposing or protecting cofactors of DHR.
Objective
UNASSIGNED
This study aims to determine drug-specific cofactors in patients with DHR.
Methods
UNASSIGNED
Retrospective file chart analysis of inpatients with suspected DHR in our department between 2015 and 2020 was performed. Descriptive statistics and multiple logistic regression were conducted for the estimation and statistical interference.
Results
UNASSIGNED
DHRs were suspected in 393 patients with 678 culprit drugs. In 183 cases, drug hypersensitivities were confirmed, mostly against nonopioid analgesic drugs and antibiotics. Multiple logistic regression analysis identified a positive association of antibiotic hypersensitivity with obesity [odds ratio (OR) 5.75, average marginal effect (AME) +24.4%] and age and a negative association with arterial hypertension, female sex, elevated immunoglobulin E (IgE), and allergic rhinitis. Hypersensitivity to nonopioid analgesics was associated with atopic dermatitis (OR 10.28, AME +28.5%), elevated IgE, and arterial hypertension.
Conclusions
UNASSIGNED
Drug-specific cofactors of DHR include obesity for antibiotics and atopic dermatitis for nonopioid analgesics, the knowledge of which may improve the risk calculation for drug provocation tests.
Identifiants
pubmed: 36686964
doi: 10.3389/falgy.2022.1097977
pmc: PMC9854260
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1097977Informations de copyright
© 2023 Kühl, Bergh, Laudes, Szymczak and Heine.
Déclaration de conflit d'intérêts
GH reports grants from Deutsche Forschungsgemeinschaft (DFG), during the conduct of the study; and personal fees from Allergopharma, Biotest, Eli Lilly, Sanofi, Abbvie, and Leti outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Exp Allergy. 2004 Oct;34(10):1597-601
pubmed: 15479276
J Dtsch Dermatol Ges. 2013 Jan;11(1):44-50
pubmed: 23181736
Ann Allergy Asthma Immunol. 2017 Oct;119(4):362-373.e2
pubmed: 28779998
Ann Allergy Asthma Immunol. 2021 Feb;126(2):197-199
pubmed: 33122126
J Investig Allergol Clin Immunol. 2009;19 Suppl 2:45-50
pubmed: 19530418
Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-273
pubmed: 20934625
J Allergy Clin Immunol. 2015 Nov;136(5):1425-6
pubmed: 26392054
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):786-94
pubmed: 23703499
Front Pharmacol. 2021 Jan 08;11:555666
pubmed: 33542684
J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):139-148.e2
pubmed: 28739365
Ann Allergy Asthma Immunol. 2007 Jul;99(1):54-8
pubmed: 17650830
Allergy. 2014 Apr;69(4):420-37
pubmed: 24697291
J Lipid Res. 2015 May;56(5):1034-42
pubmed: 25713100
J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):292-300.e3
pubmed: 26852067
Int J Mol Sci. 2017 Jul 04;18(7):
pubmed: 28677662
Allergy. 2011 Jul;66(7):818-29
pubmed: 21631520
Ann Allergy Asthma Immunol. 2021 Jul;127(1):100-108
pubmed: 33771681
JAMA Intern Med. 2020 May 1;180(5):745-752
pubmed: 32176248
Allergo J Int. 2016;25:6-10
pubmed: 27069844